Skip to main content

Cardinal Health Value Stock - Dividend - Research Selection

Cardinal health

ISIN: US14149Y1082 , WKN: 880206

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company\'s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company\'s Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Cardinal Health Stock Gets RS Rating Lift

2025-10-01
Cardinal Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Cardinal Health to Build Indianapolis Pharma Plant to Supply Growing Distribution

2025-09-30
The planned 230,000 square-foot plant is the healthcare company’s latest step in a 10-year plan to modernize and expand its distribution network.

Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs

2025-09-30
Pfizer shares rose 2.8% Wednesday midday after The Wall Street Journal reported the pharmaceutical company would unveil a plan, alongside the Trump administration, to cut drug costs later Tuesday. Here's what to know: The White House also plans to unveil a direct-to-consumer website for Americans to buy medication.

Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility

2025-09-30
Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network. The state-of-the-art forward distribution center will feature automation and the latest technology advancements in support of the segment's distribution of more than 70,000 pharmaceutical and specialty deliveries daily across the United States.

Institutional investors are Cardinal Health, Inc.'s (NYSE:CAH) biggest bettors and were rewarded after last week's US$1.7b market cap gain

2025-09-30
Key Insights Significantly high institutional ownership implies Cardinal Health's stock price is sensitive to their...

Cardinal Health Stock Scores Relative Strength Rating Upgrade

2025-09-29
Cardinal Health shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year?

2025-09-29
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Cardinal Health (CAH) have performed compared to their sector so far this year.

IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?

2025-09-29
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.

Healthcare Providers & Services Stocks Q2 Teardown: Cardinal Health (NYSE:CAH) Vs The Rest

2025-09-29
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cardinal Health (NYSE:CAH) and its peers.

Best Dividend Aristocrats For October 2025

2025-09-28
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date. Check out the promising dividend aristocrats right now.